The things that have been working, our commitment to cancer patients served in the ... Based on the most recent market data, the NGS market is growing 10% to 15% annually, and we believe we ...

Discover NeoGenomics' Q1 2025 performance with 8% revenue growth, rising NGS contributions, and strategic innovations like PanTracer Liquid Biopsy.

NHS Forth Valley has introduced the new Rapid Cancer Diagnostic Service (RCDS) aims to provide quicker answers for patience and offer peace of mind for many, who will end up getting the positive ...

A new "Cancer Care at Work" framework has been announced to enable employers and businesses to create a policy and support system for employees who receive a cancer diagnosis or are supporting a ...

Women with breast cancer in England and Wales will soon be able to access a new diagnostic based on an injectable ... the use of the technology while data is collected to see if it can provide ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

If the blood test – sometimes referred to as a liquid biopsy – performs in the trial it could offer a less-invasive alternative to traditional cancer diagnostic techniques such as tissue biopsies.

Feb. 7, 2025 — A research team has made a major discovery on how the CUL5 gene affects CAR-T cell therapy, an advanced cancer therapy ... based rapid molecular diagnostic for two forms of ...